Neogen Corporation (NEOG)

Market Cap	2.54B +103.9%
Revenue (ttm)	870.40M -2.7%
Net Income	-7.90M
EPS	-0.04
Shares Out	218.06M
PE Ratio	n/a
Forward PE	37.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,306,974
Open	11.74
Previous Close	11.74
Day's Range	11.43 - 11.79
52-Week Range	4.90 - 12.85
Beta	1.77
Analysts	Buy
Price Target	13.33 (+14.32%)
Earnings Date	Oct 8, 2026

About NEOG

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns fo...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 23, 1989
• Employees: 2,636
• Stock Exchange: NASDAQ
• Ticker Symbol: NEOG
• Website: https://www.neogen.com

Financial Performance

In fiscal year 2026, Neogen's revenue was $870.40 million, a decrease of -2.72% compared to the previous year's $894.70 million. Losses were -$7.90 million, -99.28% less than in 2025.

Analyst Summary

According to 4 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price target is $13.33, which is an increase of 14.32% from the latest price.

Price Target

$13.33

(14.32% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 29, 2026

Data Sources Report a data error